Sign inGet started

Pine Michael Craig

Insider CIK 1904458 · EYPT Chief Corp Dev.&Strat. Officer

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
EYPT EyePoint Pharmaceuticals, M Exercise deriv2024-01-062024-01-0915,285— $030,570SEC↗
EYPT EyePoint Pharmaceuticals, F Tax w/h2024-01-062024-01-095,966$20.40 $121.7K13,662SEC↗
EYPT EyePoint Pharmaceuticals, M Exercise2024-01-062024-01-0915,285— $019,628SEC↗
EYPT EyePoint Pharmaceuticals, A Award deriv2024-01-052024-01-0921,000— $021,000SEC↗
EYPT EyePoint Pharmaceuticals, A Award deriv2024-01-052024-01-0942,000— $042,000SEC↗
EYPT EyePoint Pharmaceuticals, M Exercise deriv2023-12-042023-12-0645,000— $055,000SEC↗
EYPT EyePoint Pharmaceuticals, M Exercise deriv2023-12-042023-12-1145,000— $055,000SEC↗
EYPT EyePoint Pharmaceuticals, S Sale2023-12-042023-12-0645,000$22.00 $990.0K5,343SEC↗
EYPT EyePoint Pharmaceuticals, M Exercise2023-12-042023-12-0645,000$12.62 $567.9K50,343SEC↗
EYPT EyePoint Pharmaceuticals, S Sale2023-12-042023-12-1145,000$22.00 $990.0K5,343SEC↗
EYPT EyePoint Pharmaceuticals, M Exercise2023-12-042023-12-1145,000$12.62 $567.9K50,343SEC↗
EYPT EyePoint Pharmaceuticals, S Sale2023-12-042023-12-111,000$20.79 $20.8K4,343SEC↗
EYPT EyePoint Pharmaceuticals, A Award deriv2023-06-202023-06-2245,855— $045,855SEC↗
EYPT EyePoint Pharmaceuticals, A Award deriv2023-05-252023-05-307,500— $07,500SEC↗
EYPT EyePoint Pharmaceuticals, A Award deriv2023-05-252023-05-3015,000— $015,000SEC↗
EYPT EyePoint Pharmaceuticals, A Award deriv2023-01-062023-01-1091,655— $091,655SEC↗
EYPT EyePoint Pharmaceuticals, P Buy2022-03-142022-03-151,000$12.21 $12.2K1,000SEC↗
EYPT EyePoint Pharmaceuticals, A Award deriv2022-01-102022-01-14100,000— $0100,000SEC↗